Form 4: Acadia Healthcare Director Michael Fucci Reports Acquisition of Common Stock

Director Michael Fucci reports acquiring 2,414 shares of Acadia Healthcare Company, Inc. common stock on May 23, 2024.

Summary

• On May 28, 2024, Michael Fucci, a director of Acadia Healthcare Company, Inc., filed a Form 4 with the SEC.
• The report details a transaction on May 23, 2024, where Fucci acquired 2,414 shares of common stock at a price of $0.0.
• Following the transaction, Fucci directly owns 14,789 shares of Acadia Healthcare Company, Inc.
• The acquired shares vest over a 3-year period in equal yearly installments beginning May 23, 2025.
• Fucci has also granted Brian Farley and Heather B. Dixon power of attorney to handle SEC filings related to his transactions in Acadia Healthcare securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing detailing a stock transaction. The acquisition of shares by a director is generally viewed as a positive sign, but without additional context, the impact is limited.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The acquired shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency to investors regarding the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often seen as a sign of confidence in the company.

Key Dates